Digital therapeutics and apps

FDA-cleared tools, contingency-management apps, and what happened to them.

1. News

   The first FDA-authorized app for substance use disorder, and its maker's bankruptcy

   Source date April 7, 2023 · Multi-site, unblinded, randomized trial run through the National Institute on Drug Abuse Clinical Trials Network (CTN0044), 12 weeks · 507 in the trial. The FDA's intended-use figures come from the 399 who did not name opioids as their main substance.

   In 2017 the FDA let Pear market reSET, the first mobile medical app to help treat substance use disorders. In April 2023, Pear filed for Chapter 11.